Molecular Therapy Nucleic Acids, 9, 155–161. doi: 10.1016/j.omtn.2017.09.002

Rational design of short locked nucleic acid-modified 2’-O-methyl antisense oligonucleotides for efficient exon-skipping in vitro. Le BT, Adams AM, Fletcher S, Wilton SD, and Veedu RN (2017) Molecular Therapy Nucleic Acids, 9, 155–161. doi: 10.1016/j.omtn.2017.09.002

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *